LadaTech

This article has been updated with comments from Illumina.
By a GenomeWeb staff reporter

In its suit, filed last August, LadaTech claimed that Illumina's Genome Analyzer and related products and services infringe a DNA amplification patent it holds.

LadaTech initially filed the suit in August, and said that Illumina refused to enter into a license agreement for the patent.

The suit claims that Illumina's Genome Analyzer and related products and services infringe a patent originally issued to Genelabs and now held by a firm called LadaTech.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.